Aclaris: 3Q Earnings Snapshot

November 6, 2018

WAYNE, Pa. (AP) _ Aclaris Therapeutics Inc. (ACRS) on Tuesday reported a loss of $32.7 million in its third quarter.

The Wayne, Pennsylvania-based company said it had a loss of $1.06 per share.

The specialty pharmaceutical company posted revenue of $1.6 million in the period.

Aclaris shares have fallen 52 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $11.75, a drop of 51 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACRS at https://www.zacks.com/ap/ACRS

Update hourly